Reinforcing the social compromise of accelerated approval

Nat Rev Clin Oncol. 2018 Oct;15(10):596-597. doi: 10.1038/s41571-018-0066-3.

Authors

Bishal Gyawali¹, Aaron S Kesselheim²

Affiliations

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
² Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. akesselheim@bwh.harvard.edu.

PMID: 29970919
DOI: 10.1038/s41571-018-0066-3

No abstract available

Publication types

Comment

MeSH terms

Drug Approval*
Financing, Organized
Humans
Medical Oncology*